Type IIA Secreted Phospholipase A2 in Host Defense against Bacterial Infections - Institut Pasteur Accéder directement au contenu
Article Dans Une Revue Trends in Immunology Année : 2020

Type IIA Secreted Phospholipase A2 in Host Defense against Bacterial Infections

Résumé

The enzyme type IIA secreted phospholipase A2 (sPLA2-IIA) is crucial for mammalian innate host defense against bacterial pathogens. Most studies have investigated the role of sPLA2-IIA in systemic bacterial infections, identifying molecular pathways of bacterial resistance against sPLA2-IIA-mediated killing, and providing insight into sPLA2-IIA mechanisms of action. Sensitization of (antibiotic-resistant) bacteria to sPLA2-IIA action by blocking bacterial resistance or by applying sPLA2-IIA to treat bacterial infections might represent a therapeutic option in the future. Because sPLA2-IIA is highly expressed at mucosal barriers, we also discuss how sPLA2-IIA is likely to be an important driver of microbiome composition; we anticipate that future research in this area may bring new insights into the role of sPLA2-IIA in health and disease.
Fichier non déposé

Dates et versions

pasteur-02863073 , version 1 (09-06-2020)

Identifiants

Citer

Vincent van Hensbergen, Yongzheng Wu, Nina van Sorge, Lhousseine Touqui. Type IIA Secreted Phospholipase A2 in Host Defense against Bacterial Infections. Trends in Immunology, 2020, 41 (4), pp.313-326. ⟨10.1016/j.it.2020.02.003⟩. ⟨pasteur-02863073⟩
35 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More